BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 24599305)

  • 1. Comparative genomic analysis of primary and synchronous metastatic colorectal cancers.
    Lee SY; Haq F; Kim D; Jun C; Jo HJ; Ahn SM; Lee WS
    PLoS One; 2014; 9(3):e90459. PubMed ID: 24599305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic alterations accompanying tumour evolution in colorectal cancer: tracking the differences between primary tumours and synchronous liver metastases by whole-exome sequencing.
    Mogensen MB; Rossing M; Østrup O; Larsen PN; Heiberg Engel PJ; Jørgensen LN; Hogdall EV; Eriksen J; Ibsen P; Jess P; Grauslund M; Nielsen HJ; Nielsen FC; Vainer B; Osterlind K
    BMC Cancer; 2018 Jul; 18(1):752. PubMed ID: 30029640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Heterogeneity in Therapy-Naïve Synchronous Primary Breast Cancers and Their Metastases.
    Ng CKY; Bidard FC; Piscuoglio S; Geyer FC; Lim RS; de Bruijn I; Shen R; Pareja F; Berman SH; Wang L; Pierga JY; Vincent-Salomon A; Viale A; Norton L; Sigal B; Weigelt B; Cottu P; Reis-Filho JS
    Clin Cancer Res; 2017 Aug; 23(15):4402-4415. PubMed ID: 28351929
    [No Abstract]   [Full Text] [Related]  

  • 4. Subclonal Genomic Architectures of Primary and Metastatic Colorectal Cancer Based on Intratumoral Genetic Heterogeneity.
    Kim TM; Jung SH; An CH; Lee SH; Baek IP; Kim MS; Park SW; Rhee JK; Lee SH; Chung YJ
    Clin Cancer Res; 2015 Oct; 21(19):4461-72. PubMed ID: 25979483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of primary tumour and matched metastases in colorectal cancer patients: evaluation of concordance between genomic and transcriptional profiles.
    Vignot S; Lefebvre C; Frampton GM; Meurice G; Yelensky R; Palmer G; Capron F; Lazar V; Hannoun L; Miller VA; André F; Stephens PJ; Soria JC; Spano JP
    Eur J Cancer; 2015 May; 51(7):791-9. PubMed ID: 25797355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor Heterogeneity Predicts Metastatic Potential in Colorectal Cancer.
    Joung JG; Oh BY; Hong HK; Al-Khalidi H; Al-Alem F; Lee HO; Bae JS; Kim J; Cha HU; Alotaibi M; Cho YB; Hassanain M; Park WY; Lee WY
    Clin Cancer Res; 2017 Dec; 23(23):7209-7216. PubMed ID: 28939741
    [No Abstract]   [Full Text] [Related]  

  • 7. Clonal origins and parallel evolution of regionally synchronous colorectal adenoma and carcinoma.
    Kim TM; An CH; Rhee JK; Jung SH; Lee SH; Baek IP; Kim MS; Lee SH; Chung YJ
    Oncotarget; 2015 Sep; 6(29):27725-35. PubMed ID: 26336987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of p53 mutations, microvessel density and neoangiogenesis in pairs of colorectal cancers and corresponding liver metastases.
    Kern A; Taubert H; Scheele J; Rudroff C; Mothes H; Kappler M; Bartel F; Richter KK
    Int J Oncol; 2002 Aug; 21(2):243-9. PubMed ID: 12118317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinctive Spatiotemporal Stability of Somatic Mutations in Metastasized Microsatellite-stable Colorectal Cancer.
    Jesinghaus M; Wolf T; Pfarr N; Muckenhuber A; Ahadova A; Warth A; Goeppert B; Sers C; Kloor M; Endris V; Stenzinger A; Weichert W
    Am J Surg Pathol; 2015 Aug; 39(8):1140-7. PubMed ID: 25786087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between genomic alterations and metastatic behavior of colorectal cancer identified by array-based comparative genomic hybridization.
    Sawada T; Yamamoto E; Suzuki H; Nojima M; Maruyama R; Shioi Y; Akasaka R; Kamimae S; Harada T; Ashida M; Kai M; Adachi Y; Yamamoto H; Imai K; Toyota M; Itoh F; Sugai T
    Genes Chromosomes Cancer; 2013 Feb; 52(2):140-9. PubMed ID: 23073979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of somatic alterations between matched primary and metastatic colorectal tumors characterized by whole-genome sequencing.
    Xie T; Cho YB; Wang K; Huang D; Hong HK; Choi YL; Ko YH; Nam DH; Jin J; Yang H; Fernandez J; Deng S; Rejto PA; Lee WY; Mao M
    Genomics; 2014 Oct; 104(4):234-41. PubMed ID: 25066378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of liquid biopsies for detection of emerging mutated genes in metastatic colorectal cancer.
    Furuki H; Yamada T; Takahashi G; Iwai T; Koizumi M; Shinji S; Yokoyama Y; Takeda K; Taniai N; Uchida E
    Eur J Surg Oncol; 2018 Jul; 44(7):975-982. PubMed ID: 29452859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. There is no increase in frequency of somatic mutations in metastases compared with primary colorectal carcinomas with microsatellite instability.
    Barnetson R; Eckstein R; Robinson B; Schnitzler M
    Genes Chromosomes Cancer; 2003 Oct; 38(2):149-56. PubMed ID: 12939742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastatic susceptibility locus, an 8p hot-spot for tumour progression disrupted in colorectal liver metastases: 13 candidate genes examined at the DNA, mRNA and protein level.
    Macartney-Coxson DP; Hood KA; Shi HJ; Ward T; Wiles A; O'Connor R; Hall DA; Lea RA; Royds JA; Stubbs RS; Rooker S
    BMC Cancer; 2008 Jul; 8():187. PubMed ID: 18590575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exome scale map of genetic alterations promoting metastasis in colorectal cancer.
    Goryca K; Kulecka M; Paziewska A; Dabrowska M; Grzelak M; Skrzypczak M; Ginalski K; Mroz A; Rutkowski A; Paczkowska K; Mikula M; Ostrowski J
    BMC Genet; 2018 Sep; 19(1):85. PubMed ID: 30231850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of neuroendocrine differentiation and KRAS/NRAS/BRAF/PIK3CA/TP53 mutation status in primary and metastatic colorectal cancer.
    Kleist B; Kempa M; Novy M; Oberkanins C; Xu L; Li G; Loland C; Poetsch M
    Int J Clin Exp Pathol; 2014; 7(9):5927-39. PubMed ID: 25337237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative genomic analysis of primary versus metastatic colorectal carcinomas.
    Vakiani E; Janakiraman M; Shen R; Sinha R; Zeng Z; Shia J; Cercek A; Kemeny N; D'Angelica M; Viale A; Heguy A; Paty P; Chan TA; Saltz LB; Weiser M; Solit DB
    J Clin Oncol; 2012 Aug; 30(24):2956-62. PubMed ID: 22665543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatio-temporal mutation profiles of case-matched colorectal carcinomas and their metastases reveal unique de novo mutations in metachronous lung metastases by targeted next generation sequencing.
    Kovaleva V; Geissler AL; Lutz L; Fritsch R; Makowiec F; Wiesemann S; Hopt UT; Passlick B; Werner M; Lassmann S
    Mol Cancer; 2016 Oct; 15(1):63. PubMed ID: 27756406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local recurrences at the anastomotic area are clonally related to the primary tumor in sporadic colorectal carcinoma.
    Vakiani E; Shah RH; Berger MF; Makohon-Moore AP; Reiter JG; Ostrovnaya I; Attiyeh MA; Cercek A; Shia J; Iacobuzio-Donahue CA; Solit DB; Weiser MR
    Oncotarget; 2017 Jun; 8(26):42487-42494. PubMed ID: 28476018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P53 mutations in primary tumors and subsequent liver metastases are related to survival in patients with colorectal carcinoma who undergo liver resection.
    Yang Y; Forslund A; Remotti H; Lönnroth C; Andersson M; Brevinge H; Svanberg E; Lindnér P; Hafström L; Naredi P; Lundholm K
    Cancer; 2001 Feb; 91(4):727-36. PubMed ID: 11241240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.